Flattening the curve and increasing health care capacity are vital in the fight against COVID-19 but so are these two other essential items
1. The wholesale widespread distribution of the antibody test, that is far more reliable than the more commonly used antigen test. (better in the false negative department)
2. Randomized testing of large samples of the general population as a whole. This data is necessary to allow us to obtain a better understanding of the denominator in the fatality ratio...ie. the number of actual people infected.
If we can't accurately estimate this denominator our planning models, that ultimately determine resource capacity, will be subject to a high margin of error impacting resource allocation and straining our logistic efficacy.. At the fundamental level both 1 and 2 are related
No comments:
Post a Comment